Cytokines and chemokines in neuromyelitis optica: pathogenetic and therapeutic implications. - Wikidata - awgldk - TriplyDB

Cytokines and chemokines in neuromyelitis optica: pathogenetic and therapeutic implications.

Cytokines and chemokines in neuromyelitis optica: pathogenetic and therapeutic implications.

http://www.wikidata.org/entity/Q38171871

about

Hypersensitivity Responses in the Central Nervous System Aquaporin-4 antibodies in patients treated with natalizumab for suspected MS.Markedly increased IP-10 production by blood-brain barrier in neuromyelitis optica Variants of Interleukin-7/Interleukin-7 Receptor Alpha are Associated with Both Neuromyelitis Optica and Multiple Sclerosis Among Chinese Han Population in Southeastern China B Cell, Th17, and Neutrophil Related Cerebrospinal Fluid Cytokine/Chemokines Are Elevated in MOG Antibody Associated Demyelination.NFκB signaling drives pro-granulocytic astroglial responses to neuromyelitis optica patient IgG.Immunoinflammatory diseases of the central nervous system - the tale of two cytokines.Anti-N-methyl-D-aspartate receptor encephalitis: the clinical course in light of the chemokine and cytokine levels in cerebrospinal fluid.Multiple sclerosis and neuromyelitis optica spectrum disorders: some similarities in two distinct diseases.Pain in neuromyelitis optica--prevalence, pathogenesis and therapy.Pattern Recognition of the Multiple Sclerosis Syndrome.Immunopathogenesis in Myasthenia Gravis and Neuromyelitis Optica.The HMGB1 is increased in CSF of patients with an Anti-NMDAR encephalitis.Th2 axis-related cytokines in patients with neuromyelitis optica spectrum disorders.

P2860

Q26779177-8E876877-EFAF-4F18-979B-9E2621DBDADF Q33808279-3F92963E-B2D3-4E98-9A1E-B72FA3C711D6 Q35219651-1EC348AB-690B-44D6-A078-BB27ED853B48 Q35853462-D70F8A3D-4DD9-4475-9427-B2286A3CC65B Q35937581-C12971C0-C04B-4ABD-94D1-820EA0B064E3 Q36110806-82A5444F-CCF5-4A93-92D6-70469ACAB645 Q36547012-2D4108EE-24BD-4B66-B32D-E0786A77DA51 Q36646146-A67FC056-059E-4A6B-90C8-47DCBC25F824 Q36790810-611580A6-CE5D-436E-8676-E9E8FB918D10 Q38235026-F55FA465-8503-43E5-AD49-C94F366AD2B9 Q47096340-B724061D-AE2F-4F28-8ECE-A7B6D16C788D Q47192132-3573EC51-A03A-4B1F-B2EF-756690F529A3 Q47663060-4444872D-6713-412F-9C85-2CEB2C2F3682 Q47982788-5698ADE4-7FF3-4E49-8EB6-1AFCE4D2975C

P2860

Cytokines and chemokines in neuromyelitis optica: pathogenetic and therapeutic implications.

http://www.wikidata.org/entity/Q38171871

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Cytokines and chemokines in ne ...... and therapeutic implications.

@en

type

label

Cytokines and chemokines in ne ...... and therapeutic implications.

@en

prefLabel

Cytokines and chemokines in ne ...... and therapeutic implications.

@en

P1433

Q38171871-0E86B802-DA94-4FF4-B279-61C2C090E5C0

P1476

Q38171871-C318AA8E-9365-495F-88F8-57CCF4D26163

P2093

Q38171871-6DB386CB-961D-4A1F-ADE6-B94AB505E751

Q38171871-8A987772-400D-4BF8-B6D9-4EA249E1AFB8

Q38171871-C8AE5336-73C2-4885-8545-F2B8B548AB7A

P2860

Q38171871-02B0DFF6-D06B-443F-96CF-7755570E27B8

Q38171871-0AF3D8D3-B79B-4CAB-B8FC-7544B7339BFD

Q38171871-0BA75990-E88D-49CB-B68F-B3EF377E37C8

Q38171871-14481D4E-432C-4657-A7FC-175116884663

Q38171871-160B189A-FF01-4BAB-B4EF-088483AF12DD

Q38171871-19E142F0-3BCA-4616-9005-B6A75FEA7CBD

Q38171871-240CC088-8824-46C5-933D-3A0D809E08BF

Q38171871-27C35558-79CB-428F-8B60-0C2EDBDC0B9A

Q38171871-36A76078-B67C-4333-A36C-F3D6A678EB8B

Q38171871-3DA4170E-5172-4464-A99D-8901AE71DB5F

P304

Q38171871-F0EE6AB0-C9BA-447B-8E89-2925DD01252F

P31

Q38171871-224FAF81-5DD6-44D5-9B09-4EDB23F02931

P356

Q38171871-94C160A5-8001-46CD-8694-EEDDFDD8A263

P433

Q38171871-99EF5F9C-F096-4DF6-B912-8678246958EB

P478

Q38171871-AA5E6994-64EE-4F3C-8791-5990CACB434D

P577

Q38171871-EBB42F75-9BBA-499D-ABAA-1540EF6B5248

P5875

Q38171871-8664B854-E45D-4D5D-9CFF-87C0C10E2C88

P698

Q38171871-A9D8B712-AF84-4C63-B2F4-AED43DD45C0F

P921

Q38171871-F0B57302-F088-4AA9-B624-3AF4AABFC6F3

P356

P1433

Brain Pathology

P1476

Cytokines and chemokines in ne ...... and therapeutic implications.

@en

P2093

Akiyuki Uzawa

http://www.w3.org/2001/XMLSchema#string

Masahiro Mori

http://www.w3.org/2001/XMLSchema#string

Satoshi Kuwabara

http://www.w3.org/2001/XMLSchema#string

P2860

Clinical improvement in a patient with neuromyelitis optica following therapy with the anti-IL-6 receptor monoclonal antibody tocilizumab

IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel

Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells

Interleukin 6 receptor blockade in patients with neuromyelitis optica nonresponsive to anti-CD20 therapy

Disease amelioration with tocilizumab in a treatment-resistant patient with neuromyelitis optica: implication for cellular immune responses

A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis

Astrocytes are active players in cerebral innate immunity

Intra-cerebral injection of neuromyelitis optica immunoglobulin G and human complement produces neuromyelitis optica lesions in mice.

Expression of chemokine receptors on peripheral blood lymphocytes in multiple sclerosis and neuromyelitis optica.

IL-6 induces regionally selective spinal cord injury in patients with the neuroinflammatory disorder transverse myelitis.

P304

67-73

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/BPA.12097

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

24

http://www.w3.org/2001/XMLSchema#string

P577

2014-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

259351630

http://www.w3.org/2001/XMLSchema#string

P698

24345220

http://www.w3.org/2001/XMLSchema#string

P921